Tetraphase Pharmaceuticals

$0.3772
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0012 (0.32%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell TTPH and other stocks, options, ETFs, and crypto commission-free!

About TTPH

Tetraphase Pharmaceuticals, Inc. Common Stock, also called Tetraphase Pharmaceuticals, is engaged in the development and production of novel antibiotics for serious and life-threatening bacterial infections. Read More It is currently developing a product candidate, eravacycline, a fully synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.

Employees
119
Headquarters
Watertown, Massachusetts
Founded
2006
Market Cap
20.49M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
744.84K
High Today
$0.4198
Low Today
$0.3421
Open Price
$0.40
Volume
1.10M
52 Week High
$3.21
52 Week Low
$0.225

Collections

TTPH Earnings

-$0.64
-$0.49
-$0.33
-$0.18
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.